# CDMRP Ovarian Cancer Investigator-Initiated Research Award

Source: https://welltoldgrants.com/grants/w81xwh-21-ocrp-iira-cdmrp-ovarian-cancer-investigator-initiated-research-award/  
Official notice: https://www.grants.gov/search-results-detail/331383

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 11 awards worth $11.8 million in total. Applications closed on July 8, 2021.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-21-OCRP-IIRA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | July 8, 2021 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 11 |
| Total funding | $11.8 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The OCRP Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. The application must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the application to be competitive. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project. These data may be unpublished or from the published literature. If cell lines or animals are to be used, a clear justification should be provided for the choice of proposed cell line(s) or animal model(s). Clinical trials are not supported with this award mechanism. New for FY21 is the Partnering PI Option: As a method to facilitate progress in addressing critical problems or questions through collaborative efforts, the FY21 OCRP is offering a Partnering PI Option for this award mechanism. The Partnering PI Option is structured so that two investigators, each of whom will be designated as a PI, work synergistically on a single project. If recommended for funding, each PI will be named to an individual award within the recipient organization.

## Questions people ask

### Is W81XWH-21-OCRP-IIRA still open?

No. It closed on July 8, 2021. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for CDMRP Ovarian Cancer Investigator-Initiated Research Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for CDMRP Ovarian Cancer Investigator-Initiated Research Award?

Closed July 8, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $11.8 million in total across about 11 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.